Pathos AI
Latest round
- Series D
Last raised
- Oct 2026
Total raised
- $299M
Investors
- 5
About Pathos AI
Based in Chicago, US, and founded in 2022 by CEO Ryan Fukushima, Pathos AI, Inc. operates as a provider of an AI-driven biotechnology platform that offers advanced drug development services to pharmaceutical companies looking for advanced treatment pathways. In October 2024, Pathos AI, Inc. Pathos AI, Inc. specializes in advancing drug development through its proprietary PathOS Platform, which integrates real-world oncology data and patient-derived functional genomic data. This platform enables the identification and validation of biological targets that traditional methods may overlook, ultimately focused on developing precision medicines. By partnering with biopharmaceutical companies. Their solutions cater primarily to oncology-focused pharmaceutical and biotechnology firms across various geographical markets, including North America, Europe, and select regions in Asia. Pathos AI, Inc. generates revenue primarily through strategic partnerships and licensing agreements with biopharmaceutical companies, where they co-develop and license clinical-stage therapeutics. The transaction structure encompasses B2B relationships wherein drug companies collaborate with Pathos to leverage its AI-driven insights for drug development. Pathos AI, Inc. is working on new product developments aimed at improving its PathOS Platform capabilities, with specific launches anticipated in the next 18 months. The company plans to expand its reach into European and Asian markets by 2025, focusing on collaborations with local biopharmaceutical firms.
Who invested in Pathos AI
5 investors across 2 rounds
See all investors in Pathos AI
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pathos AI
Who invested in Pathos AI?
Pathos AI has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pathos AI raised?
Pathos AI has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pathos AI last raise money?
Pathos AI's most recent round on record is a Series D, in Oct 2026.
What does Pathos AI do?
Based in Chicago, US, and founded in 2022 by CEO Ryan Fukushima, Pathos AI, Inc.
Where is Pathos AI headquartered?
Pathos AI is headquartered in Chicago, US.
Which VCs invest in companies like Pathos AI?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pathos AI's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Pathos AI? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.